Keeping Current

521 Episodes

1. Adherence to Lipid-Lowering Therapies: How Can We Tackle This Barrier Better?

   Published: 6/06/2023
2. Adherence to Lipid-Lowering Therapies: How Can We Tackle This Barrier Better?

   Published: 6/06/2023
3. A Patient Is Waiting for a Liver Transplant: What Can We Do Now and What Could We Have Done Better?

   Published: 31/05/2023
4. Reducing the Risks of Hyperkalemia in the Treatment of Heart Failure and Chronic Kidney Disease: What It Means for Management Teams

   Published: 31/05/2023
5. Dengue Prevention: Integrating Vaccination Into Comprehensive Control Strategies Across Populations

   Published: 22/05/2023
6. Early-Stage Resectable Non-Small Cell Lung Cancer: Sharing Patient Perspectives

   Published: 8/05/2023
7. Gaining Control With Early Combination Lipid-Lowering Therapy: Applying Learnings From the Queen's Gambit

   Published: 3/05/2023
8. Looking Forward to Thriving With HIV: Interventions to Improve and Maintain Health in People With HIV

   Published: 1/05/2023
9. Three Cardiovascular Risk Cases: Why and Who Should We Be Testing for Lp(a)

   Published: 18/04/2023
10. Well Begun Is Half Done: Why and How Do We Assess Activity of the Complement Pathway in the Clinic?

    Published: 14/04/2023
11. What’s New in Diabetic Eye Disease Technologies

    Published: 31/03/2023
12. Biosimilars in Multiple Sclerosis: Entering a New Era of Biologic Therapy

    Published: 30/03/2023
13. Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases

    Published: 29/03/2023
14. Global Perspectives on Anti-Vascular Endothelial Growth Factor: If, When, and How to Switch

    Published: 29/03/2023
15. Clinical Trials in Focus: Durability of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies

    Published: 28/03/2023
16. Safeguarding the CKD Patient With or Without Diabetes in Primary Care: Quick Questions, Rapid Replies

    Published: 27/03/2023
17. Optimizing Treatments in Advanced Systemic Mastocytosis With Associated Hematological Neoplasm

    Published: 27/03/2023
18. Diabetes Dialogue Part 2: Who Are Candidates for GLP-1 Receptor Agonist Therapy in Primary Care?

    Published: 24/03/2023
19. Challenging the Harmful Myths About ASCVD Management: The Experts Set the Record Straight

    Published: 23/03/2023
20. What Is the Expert Accord on Identifying and Protecting the Patient at Early Stage of CKD?

    Published: 16/03/2023